Currently out of the existing stock ratings of Roy Buchanan, 55 are a BUY (96.49%), 2 are a HOLD (3.51%).

Roy Buchanan

Work Performance Price Targets & Ratings Chart

Analyst Roy Buchanan, currently employed at JMP, carries an average stock price target met ratio of 31.06% that have a potential upside of 23.49% achieved within 101 days.

Roy Buchanan’s has documented 113 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVAC, CureVac NV at 14-Feb-2025.

Wall Street Analyst Roy Buchanan

Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 10/4/2021. The price target of $73 was fulfilled within 18 days with a profit of $12.81 (21.28%) receiving and performance score of 11.82.

Average potential price target upside

of $84.7 (24.34%) on ARGX (ARGENX NV ADR).
of $41.6 (57.93%) on HOOK (HOOKIPA PHARMA).
of $18.07 (36.23%) on ENTA (ENANTA PHARMACEUTICALS).

CVAC CureVac NV ENTA Enanta Pharmaceuticals HOOK Hookipa Pharma ARGX argenx NV ADR ABUS Arbutus Biopharma Corp DVAX Dynavax Technologies IBIO Ibio PRDS Pardes Biosciences ANTX AN2 Therapeutics GRTS Gritstone Oncology ESPR Esperion Therapeutics INO Inovio Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Roy Buchanan (JMP)